J Korean Diabetes.  2016 Jun;17(2):123-133. 10.4093/jkd.2016.17.2.123.

The Well-Being and Treatment Satisfaction of Diabetic Patients in an Outpatient Setting at a General Hospital in Korea

• Park HS
• Lee SN
• Baek MY
• Yu SH
• Eom YS
• Lee S
• Lee KY
• Kim YS
• Kim BJ
• Kim KW
• Park IB

• KMID: 2328578
• DOI: http://doi.org/10.4093/jkd.2016.17.2.123

Abstract

BACKGROUND
The aim of this study was to assess the psychological well-being and treatment satisfaction in patients with type 2 diabetes mellitus in a general hospital in Korea.
METHODS
This study included 440 type 2 diabetes patients above 20 years of age. Well-Being Questionnaire-12 (WBQ-12) and Diabetes Treatment Satisfaction Questionnaire were used to survey well-being and treatment satisfaction, respectively. WBQ-12 consists of 4 categories: negative well-being (NWB), energy (ENE), positive well-being (PWB), and general well-being (GWB).
RESULTS
There were significant associations between NWB scores and women, low education, low-income, and number of hospital admissions. Significant associations were also identified between ENE scores and men, higher education, insulin nonusers, high-income, compliance with recommended exercise, number of medications, satisfaction with treatment time, and poor glycemic control. PWB scores were significantly associated with high-income, satisfaction with waiting and treatment times, compliance with recommended diet and exercise, and number of medications. GWB scores were significantly associated with men, higher education, high-income, satisfaction with waiting and treatment times, compliance with recommended exercise, and number of medications. Treatment satisfaction was significantly associated with age, satisfaction with waiting and treatment times, compliance with recommended diet and exercise, and duration of diabetes.
CONCLUSION
Diabetes care requires psychosocial support in addition to medical care. Unlike Western studies, our study found that satisfaction with waiting and treatment times had a strong correlation with well-being and treatment satisfaction in diabetes patients.

Keyword

Diabetes; Diabetes treatment satisfaction questionnaire; Treatment satisfaction; Well-being; Well-Being questionnaire-12

MeSH Terms

Compliance
Diabetes Mellitus, Type 2
Diet
Education
Female
Hospitals, General*
Humans
Insulin
Korea*
Male
Morinda
Outpatients*
Insulin

Reference

References

1. Ko SH, Park SA, Cho JH, Ko SH, Shin KM, Lee SH, Song KH, Park YM, Ahn YB. Influence of the duration of diabetes on the outcome of a diabetes self-management education program. Diabetes Metab J. 2012; 36:222–9.

2. Cramer JA. Systematic review of adherence with medications for diabetes. Diabetes Care. 2004; 27:1218–24.

3. Saatci E, Tahmiscioglu G, Bozdemir N, Akpinar E, Ozcan S, Kurdak H. The wellbeing and treatment satisfaction of diabetic patients in primary care. Health Qual Life Outcomes. 2010; 8:67.

4. Riazi A, Bradley C, Barendse S, Ishii H. Development of the wellbeing questionnaire short-form in Japanese: the W-BQ12. Health Qual Life Outcomes. 2006; 4:40.

5. Bradley C, Gamsu D. Guidelines for encouraging psychological wellbeing: report of a Working Group of the World Health Organization Regional Office for Europe and International Diabetes Federation European Region St. Vincent declaration action programme for diabetes. Diabet Med. 1994; 11:510–6.

6. Weinberger M, Kirkman MS, Samsa GP, Cowper PA, Shortliffe EA, Simel DL, Feussner JR. The relationship between glycaemic control and health-related quality of life in patients with non insulindependent diabetes mellitus. Med Care. 1994; 32:1173–81.

7. Pouwer F, Van der Ploeg HM, Adèr HJ, Heine RJ, Snoek FJ. The 12-item wellbeing questionnaire. An evaluation of its validity and reliability in Dutch people with diabetes. Diabetes Care. 1999; 22:2004–10.

8. Özmen B, Eser E, Özkaya Kafesçiler S, Pala T, Güçlü F, Hekimsoy Z. Psychometric properties and responsiveness of the Turkish version of the diabetes treatment satisfaction questionnaire(s) on a sample of diabetics of three consecutive monitoring periods. Acta Diabetol. 2010; 47(Suppl 1):123–31.

9. Weaver M, Patrick DL, Markson LE, Martin D, Frederic I, Berger M. Issues in the measurement of satisfaction with treatment. Am J Manag Care. 1997; 3:579–94.

10. Albrecht G, Hoogstraten J. Satisfaction as determination of compliance. Community Dent Oral Epidemiol. 1998; 26:139–46.

11. Atkinson MJ, Kumar R, Cappelleri JC, Hass SL. Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM Version ll) among outpatient pharmacy consumers. Value Health. 2005; 8(Suppl 1):S9–24.

12. Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care. 2002; 25:458–63.

13. Menzin J, Langley-Hawthorne C, Friedman M, Boulanger L, Cavanaugh R. Potential short-term economic benefits of improved glycemic control: a managed care perspective. Diabetes Care. 2001; 24:51–5.

14. Hogan P, Dall T, Nikolov P. American Diabetes Association. Economic costs of diabetes in the U.S. in 2002. Diabetes Care. 2003; 26:917–32.

15. Bradley C. Handbook of psychology and diabetes: a guide to psychological measurement in diabetes research and practice. 3rd ed.New York: Psychology Press;2013. Chapter 7, Diabetes Treatment Satisfaction Questionnaire (DTSQ); p.p. 111–32.

16. Bradley C, Lewis KS. Measures of psychological wellbeing and treatment satisfaction developed from the responses of people with tablet-treated diabetes. Diabet Med. 1990; 7:445–51.

17. Bradley C. Handbook of psychology and diabetes: a guide to psychological measurement in diabetes research and practice. 3rd ed.New York: Psychology Press;2013. Chapter 6, The wellbeing questionnaire (W-BQ); p.p. 89–109.

18. Pouwer F, Snoek FJ, van der Ploeg HM, Adèr HJ, Heine RJ. The wellbeing questionnaire: evidence for a three-factor structure with 12 items (W-BQ12). Psychol Med. 2000; 30:455–62.

19. Ozer E, Sengül AM, Gedik S, Salman S, Salman F, Sargin M, Işsever H, Satman I, Yilmaz T. Diabetes education: a chance to improve wellbeing of Turkish people with type 2 diabetes. Patient Educ Couns. 2003; 51:39–44.

20. Petterson T, Lee P, Hollis S, Young B, Newton P, Dornan T. Well-being and treatment satisfaction in older people with diabetes. Diabetes Care. 1998; 21:930–5.

21. Weisman MM, Klerman GL. Sex differences and the epidemiology of depression. Arch Gen Psychiatry. 1977; 34:98–111.

22. The Diabetes Control and Complications Trial Research Group. Influence of intensive diabetes treatment on quality-of-life outcomes in the diabetes control and complications trial. Diabetes Care. 1996; 19:195–203.

23. Bott U, Mühlhauser I, Overmann H, Berger M. Validation of a diabetes-specific quality-of-life scale for patients with type 1 diabetes. Diabetes Care. 1998; 21:757–69.

24. Krousel-Wood MA, Berger L, Jiang X, Blonde L, Myers L, Webber L. Does home-based exercise improve body mass index in patients with type 2 diabetes? Results of a feasibility trial. Diabetes Res Clin Pract. 2008; 79:230–6.

25. Bradley C, Gilbride CJ. Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine. Diabetes Obes Metab. 2008; 10(Suppl 2):50–65.

26. Wredling R, Stålhammar J, Adamson U, Berne C, Larsson Y, Ostman J. Well-being and treatment satisfaction in adults with diabetes: a Swedish population-based study. Qual Life Res. 1995; 6:515–22.

27. Nicolucci A, Cucinotta D, Squatrito S, Lapolla A, Musacchio N, Leotta S, Vitali L, Bulotta A, Nicoziani P, Coronel G. QuoLITy Study Group. Clinical and socioeconomic correlates of quality of life and treatment satisfaction in patients with type 2 diabetes. Nutr Metab Cardiovasc Dis. 2009; 19:45–53.

28. Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res. 1999; 8(1–2):79–91.

29. Selby JV, Ray GT, Zhang D, Colby CJ. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care. 1997; 20:1396–402.

30. Savli H, Sevinc A. The evaluation of the Turkish version of the Well-being Questionnaire (WBQ-22) in patients with type 2 diabetes: the effects of diabetic complications. J Endocrinol Invest. 2005; 28:683–91.

31. Peyrot M, Rubin RR. Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care. 1997; 20:585–90.

32. U.K. Prospective Diabetes Study Group. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care. 1999; 22:1125–36.

33. Peyrot M, Rubin RR. Persistence of depressive symptoms in diabetic adults. Diabetes Care. 1999; 22:448–52.

34. Marra G. DIAB & TE.S Project Study Group. The DIAB.&TE.S project: how patients perceive diabetes and diabetes therapy. Acta Biomed. 2004; 75:164–70.